- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 333/38 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 333/38
Total number of patents in this class: 737
10-year publication summary
|
64
|
50
|
38
|
42
|
46
|
47
|
40
|
49
|
50
|
10
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2600 |
34 |
| Takeda Pharmaceutical Company Limited | 2961 |
27 |
| Bayer AG | 3045 |
21 |
| Astellas Pharma Inc. | 1145 |
13 |
| Bayer Cropscience AG | 2241 |
10 |
| BASF SE | 19740 |
9 |
| AstraZeneca AB | 3042 |
9 |
| Boehringer Ingelheim International GmbH | 4629 |
9 |
| Nissan Chemical Industries, Ltd. | 1822 |
9 |
| F. Hoffmann-La Roche AG | 7958 |
8 |
| Bayer Cropscience SA | 65 |
8 |
| Kissei Pharmaceutical Co., Ltd. | 215 |
7 |
| Corteva Agriscience LLC | 2494 |
7 |
| Vertex Pharmaceuticals Incorporated | 1581 |
6 |
| Aerie Pharmaceuticals, Inc. | 131 |
6 |
| EA Pharma Co., Ltd. | 77 |
6 |
| Global Blood Therapeutics, Inc. | 180 |
6 |
| Xwpharma Ltd. | 56 |
6 |
| Bayer Pharma AG | 1096 |
5 |
| Activesite Pharmaceuticals, Inc. | 18 |
5 |
| Other owners | 526 |